Medically reviewed by Mary Choy, PharmD Mounjaro (tirzepatide) and Trulicity (dulaglutide) are prescription medications that ...

综合长期和短期的成本效益分析，研究证实了与 1.5mg 度拉糖肽相比，0.5mg 和 1.0mg 的每周一次司美格鲁肽是治疗中国 2 型糖尿病（在二甲双胍治疗控制不佳的情况下）更具成本效益的治疗选择。这一研究结果为中国医疗资源的合理分配提供了重要依据，有助于临床医生做出更合适的治疗决策，提高患者的治疗效果和生活质量。

Dulaglutide has been routed to NICE Centre for Guidelines where the topic will be considered for potential inclusion within the next review of NG18: Diabetes (type 1 and type 2) in children and young ...

Trulicity (dulaglutide) is not a weight loss drug, but people receiving it may lose weight. Higher doses of Trulicity typically result in more weight loss. The FDA has not approved Trulicity as a ...

GPs are free to prescribe semaglutide to all eligible patients in line with NICE guidelines after long-term shortages have ...